Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Exeliom Biosciences →Already a subscriber? Sign in
Xcout Intel tracks Exeliom Biosciences continuously — this profile deepens as new filings, funding, people and hiring data arrive.